Kai Liu is currently a Principal Scientist at Gilead Sciences, bringing 12 years of research experience from prestigious academic institutions and the pharmaceutical industry. They earned a Ph.D. in Functional Genomics from the National University of Singapore, where they developed innovative chemical proteomic approaches. Previously, Kai held various positions including Staff Scientist at BD and Scientist at Bristol-Myers Squibb, focusing on bioinformatics and next-generation sequencing technologies. Their expertise includes NGS assay design, data processing pipelines, and strategic planning for drug discovery processes.
This person is not in the org chart
This person is not in any teams
This person is not in any offices